treatment of bacterial infections and microbial biofilms
Redesigned and repurposed_artemisinin
DeNovaMed is developing novel antibiotics to treat bacterial infections.
EnBiotix a is a product-focused bioengineering company commercializing anti-infective inventions of EnBiotix co-founder and SAB Chair Professor James J. Collins.
Encapsulation of Bacterial Pathogens
Biofilm infection treatment
Antibacterial Small Molecules, Vaccines for UTI
Endogenous human molecules as antimicrobials
Antibiotic Small Molecules
Fungal infection treatment
Anti-infective discovery company
Wintermute Biomedical is a US biopharmaceutical startup whose sole focus is to develop next-generation antibiotics in order to address the impending threat of antimicrobial resistance (AMR). ...